News
ASND
161.04
-4.14%
-6.95
Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
Benzinga · 9h ago
Analysts Predict 20% Gains Ahead For The Holdings of TCAF
NASDAQ · 1d ago
Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)
TipRanks · 1d ago
Weekly Report: what happened at ASND last week (0317-0321)?
Weekly Report · 1d ago
VISEN Pharmaceuticals Prices IPO on Hong Kong Stock Exchange
TipRanks · 5d ago
Biotech Alert: Searches spiking for these stocks today
TipRanks · 5d ago
Ascendis Pharma (ASND) Soars 10.4%: Is Further Upside Left in the Stock?
NASDAQ · 03/18 13:49
Ascendis Pharma Is Maintained at Overweight by JP Morgan
Dow Jones · 03/18 12:38
Ascendis Pharma Price Target Raised to $200.00/Share From $168.00 by JP Morgan
Dow Jones · 03/18 12:38
JP Morgan Maintains Overweight on Ascendis Pharma, Raises Price Target to $200
Benzinga · 03/18 12:27
Weekly Report: what happened at ASND last week (0310-0314)?
Weekly Report · 03/17 09:28
Optimistic Investors Push Ascendis Pharma A/S (NASDAQ:ASND) Shares Up 26% But Growth Is Lacking
Simply Wall St · 03/13 10:08
Morgan Stanley Reaffirms Their Hold Rating on Ascendis Pharma (ASND)
TipRanks · 03/10 12:17
Weekly Report: what happened at ASND last week (0303-0307)?
Weekly Report · 03/10 09:29
Ascendis Pharma’s Promising Outlook: Buy Rating Backed by Yorvipath Launch and TransCon CNP Potential
TipRanks · 03/07 07:57
Optimistic Buy Rating for Ascendis Pharma Amid Competitive Landscape in HypoPTH Market
TipRanks · 03/06 11:48
TD Cowen Sticks to Its Buy Rating for Ascendis Pharma (ASND)
TipRanks · 03/05 13:17
TimesSquare U.S. Mid Cap Growth Strategy Q4 2024 Commentary
Seeking Alpha · 03/04 18:26
Ascendis Pharma (ASND) Receives a Hold from Morgan Stanley
TipRanks · 03/03 13:06
Weekly Report: what happened at ASND last week (0224-0228)?
Weekly Report · 03/03 09:29
More
Webull provides a variety of real-time ASND stock news. You can receive the latest news about Ascendis Pharma through multiple platforms. This information may help you make smarter investment decisions.
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).